about
Stemness state regulators SALL4 and SOX2 are involved in progression and invasiveness of esophageal squamous cell carcinomaRole of SALL4 in the progression and metastasis of colorectal cancerCrosstalk between SHH and stemness state signaling pathways in esophageal squamous cell carcinoma.Negative Regulatory Role of TWIST1 on SNAIL Gene Expression.Role of Msi1 and PYGO2 in esophageal squamous cell carcinoma depth of invasion.Correlation of Wnt and NOTCH pathways in esophageal squamous cell carcinoma.Biological and Clinicopathological Significance of Cripto-1 Expression in the Progression of Human ESCC.Cancer stem cell detection and isolation.Predicting the Correlation of EZH2 and Cancer Stem Cell Markers in Esophageal Squamous Cell Carcinoma.Contribution of MAML1 in esophageal squamous cell carcinoma tumorigenesis.Expression analysis of BRUCE protein in esophageal squamous cell carcinoma.Predicting the molecular role of MEIS1 in esophageal squamous cell carcinoma.Identification of four novel mutations of the WFS1 gene in Iranian Wolfram syndrome pedigrees.Neoantigen in esophageal squamous cell carcinoma for dendritic cell-based cancer vaccine development.The cross-regulation between SOX15 and Wnt signaling pathway.SOX1 is correlated to stemness state regulator SALL4 through progression and invasiveness of esophageal squamous cell carcinoma.Association of PYGO2 and EGFR in esophageal squamous cell carcinoma.Clinicopathological sex- related relevance of musashi1 mRNA expression in esophageal squamous cell carcinoma patients.Ectopic expression of TWIST1 upregulates the stemness marker OCT4 in the esophageal squamous cell carcinoma cell line KYSE30.MAML1 and TWIST1 co-overexpression promote invasion of head and neck squamous cell carcinoma.Role of Msi1 and MAML1 in Regulation of Notch Signaling Pathway in Patients with Esophageal Squamous Cell Carcinoma.Diagnostic clinical relevance of developmental pluripotency-associated 2 (DPPA2) in colorectal cancer.Aberrant expression of DPPA2 and HIWI genes in colorectal cancer and their impacts on poor prognosis.High frequency of microsatellite instability in sporadic colorectal cancer patients in Iran.TWIST1 upregulates the MAGEA4 oncogene.BRUCE Protein, New Marker for Targeted Therapy of Gastric Carcinoma.Contribution of EVX1 in Aggressiveness of Esophageal Squamous Cell Carcinoma.HES1 as an independent prognostic marker in esophageal squamous cell carcinoma.High frequency of Neuropeptide Y Leu7Pro polymorphism in an Iranian population and its association with coronary artery disease.SALL4 as a new biomarker for early colorectal cancers.Role of hMLH1 and E-cadherin promoter methylation in gastric cancer progression.Expression analysis elucidates the roles of MAML1 and Twist1 in esophageal squamous cell carcinoma aggressiveness and metastasis.Cancer-testis gene expression profiling in esophageal squamous cell carcinoma: identification of specific tumor marker and potential targets for immunotherapy.Ectopic Expression of Human DPPA2 Gene in ESCC Cell Line Using Retroviral System.Molecular Signaling in Tumorigenesis of Gastric CancerAssociation of Two CD44 Polymorphisms with Clinical Outcomes of Gastric Cancer PatientsWNT and NOTCH signaling pathways as activators for epidermal growth factor receptor in esophageal squamous cell carcinomaQuantitative analysis of TEM-8 and CEA tumor markers indicating free tumor cells in the peripheral blood of colorectal cancer patientsRole of MAML1 in targeted therapy against the esophageal cancer stem cellsNotch Signaling Target Genes are Directly Correlated to Esophageal Squamous Cell Carcinoma Tumorigenesis
P50
Q28236550-4AE4111E-C9F8-458F-8B15-909C945CA7C7Q28284562-238F8F38-C514-441B-8CED-36066A840E21Q33714744-8CBE1852-2BA9-43E1-835F-59B2C6EE8FE2Q36082862-9A2290CE-C303-46B0-8105-58FF2A26FAB8Q36849685-09FD1818-DC8C-4C12-BCD1-626876EFDFBEQ36940803-6D7B3D76-DA54-4CED-BB70-6331C3046FA8Q37694077-E72D6AD3-8610-4BD1-ACD9-F3DB4F3BF914Q38234251-1E2CEEC3-1043-4E7A-BFCC-18608B8823D2Q38691864-E918E68C-5545-4832-9F49-BA7F4F83FDB7Q38711252-FFE635B5-91C3-4F92-AA69-138ACCBEA3DDQ38744691-3DDEE8B9-C11F-49CA-BCBE-BBF3D49EFAC5Q38840280-88D4CD97-787A-4858-833E-1EF39B5A9710Q38842178-1AE83788-4AD8-4B9D-8D5B-483BB0F60376Q38960752-46F284D5-A1D3-41AD-AFF8-430AEA668D10Q39090367-609E59CC-87FF-424F-BE36-A97E7C020334Q40601741-EA14F01F-007F-49AF-BBF7-590174231E59Q43622554-5A80B1A1-1538-4228-9245-9E5BCBCDFDE6Q45308046-B69356F9-CED7-4BB6-8121-641F31DFDDFDQ47152626-C410425B-A5EC-4E47-8E7B-3668DFFFA8BBQ48245269-737A7AE6-0FFE-41B3-99CE-9617CE892CFBQ50569009-0A758A0C-2FED-4461-B9D1-40D86236D1C3Q50616104-9F275042-5857-4D18-82A1-B7EDA24BF648Q50688143-5C9EE489-58F1-4EF8-9A4D-D7B2E313A51AQ51373302-747F179E-BA42-4FDB-BD03-88D7FCAD9FEFQ51456107-AADCCD08-B2DB-4CDD-9E0A-A1CA0104C72CQ51521776-480BDDA3-B64D-400C-8457-29A374F15598Q52903652-CF04E735-67FE-4488-93D7-E113271B7458Q53026426-61D1B42B-4499-40FB-83B3-C5FEBFAAE633Q53674379-AEB82ECF-5E03-4155-B0CC-247D5C8A9C2DQ54193733-B01034BE-173B-47F9-ADB8-119EFF0D8336Q54244033-0C8309F5-0997-4EC9-A62D-77F0167D185AQ54343559-2D30FC27-EC9B-43B5-9037-018DC064BCECQ54369457-6788D79F-ECE4-45AF-9D0A-D5760A908AC3Q55039045-D9BD5FD6-2F5D-45DC-AA91-7797C01E49A1Q55429664-E0688C76-295C-43E2-A659-DF8AD0A5FDEEQ55561308-1FFA0E19-F079-4AB4-9CCF-0E9E7E4C3935Q57193567-C4B3DFC3-9EEB-4A88-8CF7-80353798B6DCQ59103179-2BF54145-23DC-46E0-B1F4-4E7B30D5212CQ64109561-2FB51F37-88FA-4C86-A601-4CAD9697C8E3Q85895160-00D34C8F-B5C1-4EDC-99F2-C3E849D5DDDF
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mohammad Mahdi Forghanifard
@ast
Mohammad Mahdi Forghanifard
@en
Mohammad Mahdi Forghanifard
@es
Mohammad Mahdi Forghanifard
@nl
Mohammad Mahdi Forghanifard
@sl
type
label
Mohammad Mahdi Forghanifard
@ast
Mohammad Mahdi Forghanifard
@en
Mohammad Mahdi Forghanifard
@es
Mohammad Mahdi Forghanifard
@nl
Mohammad Mahdi Forghanifard
@sl
prefLabel
Mohammad Mahdi Forghanifard
@ast
Mohammad Mahdi Forghanifard
@en
Mohammad Mahdi Forghanifard
@es
Mohammad Mahdi Forghanifard
@nl
Mohammad Mahdi Forghanifard
@sl
P106
P1153
37123782400
P31
P496
0000-0002-7691-6897